Top 10 Companies in the (S)-Glycidylphthalimide (CAS No. 161596-47-0) Market (2026): Market Leaders Powering Global Chiral Chemistry

MARKET INSIGHTS

Global (S)-Glycidylphthalimide (CAS No. 161596-47-0) market size was valued at USD 28.4 million in 2025. The market is projected to grow from USD 30.1 million in 2026 to USD 52.6 million by 2034, exhibiting a CAGR of 7.2% during the forecast period.

(S)-Glycidylphthalimide is a chiral epoxide compound derived from phthalimide, widely recognized as a versatile enantiopure building block in asymmetric synthesis. The compound features an epoxide functional group attached to a phthalimide moiety in the (S)-configuration, making it particularly valuable for the synthesis of optically active pharmaceuticals, agrochemicals, and fine chemicals where stereospecificity is critical to efficacy and safety.

The market is gaining steady traction driven by the expanding demand for chiral intermediates in pharmaceutical manufacturing and the growing emphasis on enantioselective drug development. Because regulatory agencies increasingly require chiral purity in active pharmaceutical ingredients, manufacturers are investing more heavily in stereospecific reagents such as (S)-Glycidylphthalimide. Furthermore, its role in synthesizing beta‑blockers and other cardiovascular compounds continues to reinforce its commercial relevance across global fine chemical supply chains.

(S)-Glycidylphthalimide (CAS No. 161596-47-0) Market – View in Detailed Research Report

🔟 1. Sigma‑Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany / New Jersey, USA
Key Offering: High‑purity chiral epoxides and fine chemicals for pharmaceutical R&D

Sigma‑Aldrich is a leading supplier of specialty chemicals, offering a broad portfolio of chiral building blocks, including (S)-Glycidylphthalimide. The company’s robust analytical capabilities, including chiral HPLC and optical rotation measurements, ensure compliance with stringent regulatory standards required for pharmaceutical intermediates.

Sustainability & Growth Initiatives:

• Investment in green chemistry processes to reduce solvent usage and waste generation.
• Implementation of ISO 14001 environmental management systems across manufacturing sites.
• Collaboration with academic institutions to develop sustainable synthesis routes.

9️⃣ 2. TCI Chemicals

Headquarters: Tokyo, Japan
Key Offering: Custom synthesis of chiral epoxides and protection/deprotection reagents

TCI Chemicals provides high‑quality chiral intermediates to the pharmaceutical and fine‑chemical sectors. Their expertise in asymmetric synthesis and resolution techniques allows them to deliver (S)-Glycidylphthalimide with enantiomeric excess (ee) exceeding 99%.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources in manufacturing facilities.
• Development of solvent‑free reaction protocols.
• Participation in industry consortia promoting circular economy in chemical production.

8️⃣ 3. Combi‑Blocks Inc.

Headquarters: Newark, USA
Key Offering: Research‑grade chiral building blocks and custom synthesis services

Combi‑Blocks specializes in providing high‑purity chiral reagents for academic and industrial research. Their (S)-Glycidylphthalimide is produced under GMP‑compliant conditions, ensuring traceability and quality for API development.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient manufacturing processes.
• Use of biodegradable packaging materials.
• Collaboration with CROs to streamline green chemistry workflows.

7️⃣ 4. Oakwood Chemical

Headquarters: Columbus, USA
Key Offering: Industrial‑grade chiral epoxides for large‑scale API production

Oakwood Chemical delivers high‑purity (≥99%) (S)-Glycidylphthalimide to pharmaceutical manufacturers, supporting scalable synthesis of chiral intermediates for cardiovascular drugs.

Sustainability & Growth Initiatives:

• Adoption of waste‑minimization protocols in synthesis.
• Investment in advanced purification technologies to reduce solvent consumption.
• Partnerships with global pharma companies to develop sustainable production pipelines.

6️⃣ 5. Fluorochem Ltd.

Headquarters: London, United Kingdom
Key Offering: Fluorinated chiral intermediates and specialty epoxides

Fluorochem supplies (S)-Glycidylphthalimide with precise optical purity, supporting the development of fluorinated APIs and advanced materials.

Sustainability & Growth Initiatives:

• Implementation of closed‑loop solvent recovery systems.
• Use of renewable feedstocks for epoxide synthesis.
• Engagement in EU green chemistry initiatives.

5️⃣ 6. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Broad portfolio of fine chemicals and specialty intermediates for pharma and agrochemicals

BASF’s (S)-Glycidylphthalimide is produced using proprietary asymmetric epoxidation catalysts, ensuring high enantiomeric excess and scalability for commercial API manufacturing.

Sustainability & Growth Initiatives:

• Investment in low‑energy catalytic processes.
• Development of bio‑based solvents and reagents.
• Commitment to the UN Sustainable Development Goals through chemical innovation.

4️⃣ 7. Lonza Group

Headquarters: Basel, Switzerland
Key Offering: Contract development and manufacturing services for pharma intermediates

Lonza offers (S)-Glycidylphthalimide as part of its custom synthesis portfolio, enabling rapid scale‑up of chiral API intermediates for global pharmaceutical clients.

Sustainability & Growth Initiatives:

• Implementation of digital twins for process optimization.
• Use of renewable energy in manufacturing sites.
• Partnerships with biotech startups to develop green synthesis routes.

3️⃣ 8. Evonik

Headquarters: Essen, Germany
Key Offering: Specialty chemicals for pharma, cosmetics, and materials science

Evonik supplies (S)-Glycidylphthalimide with high optical purity, supporting the synthesis of chiral drugs and advanced materials.

Sustainability & Growth Initiatives:

• Development of solvent‑free epoxidation processes.
• Adoption of circular economy principles in chemical manufacturing.
• Investment in renewable feedstock sourcing.

2️⃣ 9. Zhengzhou Alfa Chemical

Headquarters: Zhengzhou, China
Key Offering: Bulk chiral intermediates for API production

Zhengzhou Alfa Chemical delivers (S)-Glycidylphthalimide at competitive pricing while maintaining rigorous quality control for pharmaceutical clients.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient manufacturing processes.
• Use of green solvents and recyclable packaging.
• Collaboration with Chinese pharma giants to develop sustainable API supply chains.

1️⃣ 10. Hangzhou Dayangchem Co., Ltd.

Headquarters: Hangzhou, China
Key Offering: Custom synthesis and bulk production of chiral epoxides

Hangzhou Dayangchem provides high‑purity (S)-Glycidylphthalimide for both research and commercial API manufacturing, with a focus on scalability and cost efficiency.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources in production facilities.
• Implementation of waste‑minimization protocols.
• Partnerships with global CROs to promote green chemistry practices.

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/307890/glycidylphthalimide-market

Get Full Report: https://www.24chemicalresearch.com/reports/307890/glycidylphthalimide-market

🌍 Outlook: The Future of (S)-Glycidylphthalimide Market

The (S)-Glycidylphthalimide market is poised for sustained growth driven by the global shift toward enantiopure drug development and the expansion of biopharmaceutical manufacturing in emerging economies. Key factors shaping the outlook include regulatory tightening on chiral purity, increased investment in green chemistry, and the adoption of continuous manufacturing platforms that leverage the compound’s well‑defined reactivity.

📈 Future Trends Shaping the Market

• Growth of flow‑chemistry and continuous synthesis for chiral intermediates.
• Expansion of beta‑blocker and cardiovascular drug pipelines requiring high‑purity epoxides.
• Advancements in biocatalysis and enzymatic resolution offering greener alternatives.
• Increased demand from contract development and manufacturing organizations (CDMOs) for scalable chiral reagents.
• Enhanced regulatory frameworks promoting sustainability and traceability in chemical production.